Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,047,701 papers from all fields of science
Search
Sign In
Create Free Account
Estrogen Receptor Status - Clinical Trial Eligibility Criteria
Known as:
ER Status
, Estrogen Receptor Status
The estrogen receptor level measured in a primary tumor or in metastases. There are essentially two distinct forms of breast cancer, one that tends…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Clinical production , stability studies and PET imaging with 16-α-[ 18 F ] fluoroestradiol ( [ 18 F ] FES ) in ER positive breast cancer patients
Piyush Kumar
,
J. Mercer
,
Courtney Doerkson
,
K. Tonkin
,
A. McEwan
2007
Corpus ID: 53519622
Purpose: F-Fluoroestradiol [F]FES has emerged as a valuable PET tracer to predict the response to hormone therapy in recurrent or…
Expand
2002
2002
Erfolge und Komplikationen der brusterhaltenden Mammakarzinomtherapie: Ergebnisse einer Langzeitbeobachtung
B. Strobl
,
W. Janni
,
+5 authors
T. Dimpfl
2002
Corpus ID: 71214384
Purpose: Over the last decades, breast conserving therapy increasingly occupied a leading role in breast cancer treatment…
Expand
2000
2000
New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status
E. Jacobs
,
P. Bulpitt
,
Ian G.C. Coutts
,
J. Robertson
Anti-Cancer Drugs
2000
Corpus ID: 23956210
Calmodulin plays a key role in the regulation of cell proliferation and calmodulin antagonists may offer a new therapeutic…
Expand
Review
1998
Review
1998
Prognostic importance of p53 and c-erbB-2 oncoproteins overexpression in patients with breast cancer.
S. Chariyalertsak
,
S. Chariyalertsak
,
A. Cheirsilpa
,
K. Chindavijak
Journal of the Medical Association of Thailand…
1998
Corpus ID: 9850534
Using immunohistochemistry, 119 breast cancer tissues were examined for overexpression of p53 and c-erbB-2 oncogene proteins. In…
Expand
1998
1998
Determination of cytosol c-erbB-2 protein in breast cancer by sandwich enzyme immunoassay.
S. Imoto
,
H. Ohkura
,
+8 authors
K. Mukai
Japanese Journal of Clinical Oncology
1998
Corpus ID: 8049823
We determined cytosol c-erbB-2 protein levels using a sandwich enzyme immunoassay in benign breast disease and primary and…
Expand
1997
1997
Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
Bela Bodey
,
Kaiser He
Anticancer Research
1997
Corpus ID: 34463460
To date, no true tissue specific antigen has been discovered. Prostate-specific antigen (PSA) was initially reported to be a…
Expand
1997
1997
Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients
G. Clark
,
J. Harvey
,
C. Osborne
,
D. Allred
1997
Corpus ID: 199644410
1986
1986
Pattern of metastases in human breast carcinoma in relation to estrogen receptor status.
C. Kamby
,
C. Rose
,
H. Iversen
,
N. Holm
,
K. Andersen
,
S. Thorpe
Anticancer Research
1986
Corpus ID: 45812188
The distribution of metastases at the first recurrence of breast cancer was studied in 57 estrogen receptor (ER) positive and in…
Expand
1985
1985
Factors associated with prognosis in human breast cancer. V. The simultaneous use of estrogen and progesterone receptor measurements for prediction of short-term relapse.
M. Pascual
,
A. Macías
,
L. Moreno
,
A. Lage
Neoplasma (Bratislava)
1985
Corpus ID: 19402538
Prediction of individual fate of breast cancer patients is one of the most important subjects studied because of the…
Expand
1984
1984
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
S. Rivkin
,
H. Glucksberg
,
M. Foulkes
Recent results in cancer research. Fortschritte…
1984
Corpus ID: 46484791
The disease-free interval and overall survival of women with operable breast cancer with positive axillary nodes has not improved…
Expand